These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells. Soares-da-Silva P; Serrão MP; Vieira-Coelho MA; Pestana M Br J Pharmacol; 1998 Jan; 123(1):13-22. PubMed ID: 9484849 [TBL] [Abstract][Full Text] [Related]
26. Tryptophan depletion, serotonin, and depression: where do we stand? Neumeister A Psychopharmacol Bull; 2003; 37(4):99-115. PubMed ID: 15131521 [TBL] [Abstract][Full Text] [Related]
27. [Clinical examples of tryptophan metabolism disorders]. Allgén LG Nord Med; 1971 Aug; 85(31):943-4. PubMed ID: 5569722 [No Abstract] [Full Text] [Related]
28. Editorial: Tryptophan and depression. Br Med J; 1976 Jan; 1(6004):242-3. PubMed ID: 764928 [No Abstract] [Full Text] [Related]
29. Amine metabolism in brain. Ashcroft GW Proc R Soc Med; 1969 Nov; 62(11 Part 1):1099-101. PubMed ID: 5356862 [No Abstract] [Full Text] [Related]
30. [Tryptophan and amitriptyline in the treatment of depression (double blind study)]. Ayuso Gutiérrez JL; López-Ibor Aliño JL; Montejo Iglesias ML Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(3):471-6. PubMed ID: 4585396 [No Abstract] [Full Text] [Related]
32. [Tryptophan and amitriptyline in the treatment of depression (double blind study)]. Ayuso Gutiérrez JL; López-Ibor Aliño JJ; Montejo Iglesias L Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(3):471-6. PubMed ID: 4585397 [No Abstract] [Full Text] [Related]
33. Lithium enhancement of central 5-HT transmission induced by 5-HT precursors. Sangdee C; Franz DN Biol Psychiatry; 1980 Feb; 15(1):59-75. PubMed ID: 6244011 [TBL] [Abstract][Full Text] [Related]
34. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease. Rocchitta G; Migheli R; Esposito G; Marchetti B; Desole MS; Miele E; Serra PA J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555 [TBL] [Abstract][Full Text] [Related]
35. [Therapeutic use of L-dopa]. Kuran W Wiad Lek; 1975 Sep; 28(17):1467-72. PubMed ID: 1099814 [No Abstract] [Full Text] [Related]
36. [Treatment of depression and sleep disorders. Significance of serotonin and L-tryptophan in pathophysiology and therapy]. Riemann D; Vorderholzer U Fortschr Med; 1998 Nov; 116(32):40-2. PubMed ID: 9880951 [TBL] [Abstract][Full Text] [Related]
37. Biochemical aspects of depression. Coppen AJ Int Psychiatry Clin; 1969; 6(2):53-81. PubMed ID: 5817856 [No Abstract] [Full Text] [Related]
38. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Hornykiewicz O Amino Acids; 2002; 23(1-3):65-70. PubMed ID: 12373520 [TBL] [Abstract][Full Text] [Related]
39. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Mercuri NB; Bernardi G Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832 [TBL] [Abstract][Full Text] [Related]